Question 1

What is an analyst price target?

Accepted Answer

A price target is an analyst's 12-month projection of a stock's fair value, derived from financial models like discounted cash flow (DCF) or comparable company analysis. It is an estimate, not a guarantee, and targets are revised as new earnings data or macro conditions change.

Question 2

How accurate are analyst price targets?

Accepted Answer

Research consistently shows that consensus price targets skew optimistic — analysts working for investment banks have incentive to maintain positive relationships with companies. Studies suggest the average target is met about half the time within 12 months. Use targets as one data point, not the sole basis for a decision.

Question 3

What does a Buy, Hold, or Sell rating mean?

Accepted Answer

Buy (or Outperform/Overweight) means the analyst expects the stock to beat the market. Hold (or Neutral/Market Perform) signals expected in-line returns. Sell (or Underperform/Underweight) means the analyst expects the stock to lag. Sell ratings are rare — fewer than 5% of ratings on average — because of banking relationships.

Question 4

What does the recommendation mean score mean?

Accepted Answer

The recommendation mean converts ratings to a 1–5 scale: 1.0 = Strong Buy, 2.0 = Buy, 3.0 = Hold, 4.0 = Underperform, 5.0 = Sell. A mean below 2.0 indicates strong bullish consensus; above 3.5 suggests most analysts are cautious or bearish.

Question 5

Why is the high price target so much higher than the low?

Accepted Answer

Analysts use different financial models, growth assumptions, and discount rates. A bull-case analyst may assume 20% revenue growth; a bear-case analyst may assume 5%. Macro disagreements (interest-rate paths, sector rotation) further widen the range. A wide spread indicates genuine uncertainty about the company's outlook.

Question 6

How many analysts typically cover a stock?

Accepted Answer

Large-cap S&P 500 companies often have 20–40 analysts. Mid-caps have 8–15. Small-caps may have 3–5 or none at all. Less coverage means larger price gaps when surprises occur, and consensus estimates are less reliable with fewer data points.

MRNA Price Target & Analyst Forecast